Logo image of COUR

COURSERA INC (COUR) Stock Fundamental Analysis

NYSE:COUR - New York Stock Exchange, Inc. - US22266M1045 - Common Stock - Currency: USD

12.17  -0.47 (-3.72%)

After market: 12.19 +0.02 (+0.16%)

Fundamental Rating

4

Overall COUR gets a fundamental rating of 4 out of 10. We evaluated COUR against 72 industry peers in the Diversified Consumer Services industry. COUR has a great financial health rating, but its profitability evaluates not so good. COUR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

COUR had positive earnings in the past year.
COUR had a positive operating cash flow in the past year.
COUR had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: COUR reported negative operating cash flow in multiple years.
COUR Yearly Net Income VS EBIT VS OCF VS FCFCOUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

With a Return On Assets value of -5.19%, COUR perfoms like the industry average, outperforming 47.22% of the companies in the same industry.
COUR has a Return On Equity (-8.12%) which is in line with its industry peers.
Industry RankSector Rank
ROA -5.19%
ROE -8.12%
ROIC N/A
ROA(3y)-13.24%
ROA(5y)-14.17%
ROE(3y)-19.16%
ROE(5y)-20.97%
ROIC(3y)N/A
ROIC(5y)N/A
COUR Yearly ROA, ROE, ROICCOUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

COUR has a better Gross Margin (54.37%) than 66.67% of its industry peers.
In the last couple of years the Gross Margin of COUR has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for COUR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.81%
GM growth 5Y0.79%
COUR Yearly Profit, Operating, Gross MarginsCOUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

COUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
COUR has more shares outstanding than it did 1 year ago.
The number of shares outstanding for COUR has been increased compared to 5 years ago.
COUR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
COUR Yearly Shares OutstandingCOUR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
COUR Yearly Total Debt VS Total AssetsCOUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

COUR has an Altman-Z score of 3.23. This indicates that COUR is financially healthy and has little risk of bankruptcy at the moment.
COUR's Altman-Z score of 3.23 is fine compared to the rest of the industry. COUR outperforms 72.22% of its industry peers.
COUR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.23
ROIC/WACCN/A
WACC8.87%
COUR Yearly LT Debt VS Equity VS FCFCOUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

COUR has a Current Ratio of 2.55. This indicates that COUR is financially healthy and has no problem in meeting its short term obligations.
COUR's Current ratio of 2.55 is fine compared to the rest of the industry. COUR outperforms 77.78% of its industry peers.
COUR has a Quick Ratio of 2.55. This indicates that COUR is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of COUR (2.55) is better than 79.17% of its industry peers.
Industry RankSector Rank
Current Ratio 2.55
Quick Ratio 2.55
COUR Yearly Current Assets VS Current LiabilitesCOUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

5

3. Growth

3.1 Past

COUR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 100.00%, which is quite impressive.
Looking at the last year, COUR shows a small growth in Revenue. The Revenue has grown by 7.11% in the last year.
COUR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 30.38% yearly.
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)7.11%
Revenue growth 3Y18.71%
Revenue growth 5Y30.38%
Sales Q2Q%9.84%

3.2 Future

COUR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.90% yearly.
Based on estimates for the next years, COUR will show a small growth in Revenue. The Revenue will grow by 6.67% on average per year.
EPS Next Y5%
EPS Next 2Y12.82%
EPS Next 3Y13.9%
EPS Next 5YN/A
Revenue Next Year7.23%
Revenue Next 2Y6.43%
Revenue Next 3Y6.67%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
COUR Yearly Revenue VS EstimatesCOUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
COUR Yearly EPS VS EstimatesCOUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

COUR is valuated quite expensively with a Price/Earnings ratio of 28.98.
COUR's Price/Earnings ratio is in line with the industry average.
COUR's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.82.
A Price/Forward Earnings ratio of 28.12 indicates a quite expensive valuation of COUR.
COUR's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 36.21. COUR is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 28.98
Fwd PE 28.12
COUR Price Earnings VS Forward Price EarningsCOUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, COUR is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 25.17
EV/EBITDA N/A
COUR Per share dataCOUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates COUR does not grow enough to justify the current Price/Earnings ratio.
COUR's earnings are expected to grow with 13.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.8
PEG (5Y)N/A
EPS Next 2Y12.82%
EPS Next 3Y13.9%

More info and screens

0

5. Dividend

5.1 Amount

COUR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COURSERA INC

NYSE:COUR (8/1/2025, 8:04:00 PM)

After market: 12.19 +0.02 (+0.16%)

12.17

-0.47 (-3.72%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)07-24 2025-07-24/amc
Earnings (Next)10-22 2025-10-22/amc
Inst Owners78.95%
Inst Owner Change-0.07%
Ins Owners6.6%
Ins Owner Change1.75%
Market Cap1.96B
Analysts73.33
Price Target10.12 (-16.84%)
Short Float %3.88%
Short Ratio2.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)42.93%
Min EPS beat(2)36.12%
Max EPS beat(2)49.74%
EPS beat(4)4
Avg EPS beat(4)133.56%
Min EPS beat(4)36.12%
Max EPS beat(4)356%
EPS beat(8)8
Avg EPS beat(8)1329.89%
EPS beat(12)12
Avg EPS beat(12)910.27%
EPS beat(16)14
Avg EPS beat(16)685.05%
Revenue beat(2)2
Avg Revenue beat(2)0.91%
Min Revenue beat(2)0.22%
Max Revenue beat(2)1.6%
Revenue beat(4)2
Avg Revenue beat(4)0.14%
Min Revenue beat(4)-0.77%
Max Revenue beat(4)1.6%
Revenue beat(8)5
Avg Revenue beat(8)0.31%
Revenue beat(12)9
Avg Revenue beat(12)1.29%
Revenue beat(16)11
Avg Revenue beat(16)0.69%
PT rev (1m)0.85%
PT rev (3m)3.93%
EPS NQ rev (1m)9.34%
EPS NQ rev (3m)-19.53%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.3%
Revenue NQ rev (1m)4.37%
Revenue NQ rev (3m)3.96%
Revenue NY rev (1m)2.11%
Revenue NY rev (3m)3.04%
Valuation
Industry RankSector Rank
PE 28.98
Fwd PE 28.12
P/S 2.72
P/FCF 25.17
P/OCF 16.92
P/B 3.13
P/tB 3.27
EV/EBITDA N/A
EPS(TTM)0.42
EY3.45%
EPS(NY)0.43
Fwd EY3.56%
FCF(TTM)0.48
FCFY3.97%
OCF(TTM)0.72
OCFY5.91%
SpS4.47
BVpS3.88
TBVpS3.72
PEG (NY)5.8
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.19%
ROE -8.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.37%
FCFM 10.81%
ROA(3y)-13.24%
ROA(5y)-14.17%
ROE(3y)-19.16%
ROE(5y)-20.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.81%
GM growth 5Y0.79%
F-Score5
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 141.09%
Cap/Sales 5.27%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.55
Quick Ratio 2.55
Altman-Z 3.23
F-Score5
WACC8.87%
ROIC/WACCN/A
Cap/Depr(3y)108%
Cap/Depr(5y)109.75%
Cap/Sales(3y)3.84%
Cap/Sales(5y)3.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y5%
EPS Next 2Y12.82%
EPS Next 3Y13.9%
EPS Next 5YN/A
Revenue 1Y (TTM)7.11%
Revenue growth 3Y18.71%
Revenue growth 5Y30.38%
Sales Q2Q%9.84%
Revenue Next Year7.23%
Revenue Next 2Y6.43%
Revenue Next 3Y6.67%
Revenue Next 5YN/A
EBIT growth 1Y39.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year211.42%
EBIT Next 3Y71.4%
EBIT Next 5YN/A
FCF growth 1Y527.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5081.12%
OCF growth 3Y279.12%
OCF growth 5YN/A